Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009-

Endocrine Journal

Volumn 58, Issue 9, 2011, Pages 711-721

  Nishikawa, Tetsuo ^a   Omura, Masao ^a   Satoh, Fumitoshi ^b   Shibata, Hirotaka ^c   Takahashi, Katsutoshi ^d   Tamura, Naohisa ^e   Tanabe, Akiyo ^f  

^a YOKOHAMA ROSAI HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e Center for Cerebrovascular Disease   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Adrenal vein sampling; Guidelines; Hypertension; Primary aldosteronism; The Japan Endocrine Society

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUDRALAZINE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; FUROSEMIDE; MANIDIPINE; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; NIFEDIPINE;

ADENOMA; ADRENAL HYPERPLASIA; ADRENAL VEIN SAMPLING; ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ANTIHYPERTENSIVE THERAPY; BLOOD SAMPLING; CAPTOPRIL CHALLENGE TEST; CARDIOVASCULAR DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG WITHDRAWAL; ESSENTIAL HYPERTENSION; EVALUATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENERAL PRACTITIONER; HEALTH CARE FACILITY; HUMAN; HYPERTENSION; HYPOKALEMIA; JAPAN; LABORATORY TEST; MEDICAL SOCIETY; PATIENT MONITORING; PLASMA RENIN ACTIVITY; POSTGRADUATE EDUCATION; PRACTICE GUIDELINE; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PROFESSIONAL STANDARD; PROVOCATION TEST; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALINE LOADING TEST; SAMPLING; SCREENING TEST; SURGICAL TECHNIQUE; UPRIGHT FUROSEMIDE LOADING TEST; VALIDATION PROCESS;

ALDOSTERONE; HUMANS; HYPERALDOSTERONISM;

EID: 80053920837     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0133     Document Type: Review

References (21)

1. Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T (1995) Vascular complications in patients with aldosterone producing adenoma in Japan: Comparative study with essential hypertension. J Endocrinol Invest 18: 370-373.
2. Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G (1999) Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 33: 261-266.
3. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, Seki T, Demura R, Demura H (1997) Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than inpatients with other types of secondary hypertension. Hypertens Res 20: 85-90.
4. Sherwin RP and Conn JW (1964) Present status of pathology of adrenal gland in hypertension. Am J Surg 107: 136-143.
5. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281.
6. Nishikawa T and Omura M (2000) Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother 54: S83-85.
7. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193-202.
8. Naruse M, Tanaka T, Otani S, Ogawa J, Tanabe M, Ishizuka N (2009) PHAS-J Study Group-A study on the frequency of PHAS in hypertensive patients in Japan using the network of the National Hospital Organization (NHO). Nippon Naibunpi Gakkai Zasshi 85: 246S. (In Japanese)
9. Komiya I, Yamada T, Takasu N, Asawa T, Akamine H, Yagi N, Nagasawa Y, Ohtsuka H, Miyahara Y, Sakai H, Sato A, Aizawa T (1997) An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and renin-aldosterone system. J Hypertens 15: 65-72.
10. Committee for the Preparation of Guidelines for the Treatment of Hypertension, Japanese Society of Hypertension. Guidelines for the Treatment of Hypertension 2009. Life Science Publishing, Tokyo, 2009. (In Japanese)
11. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2006) Clinical Characteristics of aldos-terone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 29: 883-889.
12. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch Intern Med 141: 1589-1593.
13. Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K (2003) Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab 88: 2489-2494.
14. Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A, Morimoto R, Sato A, Takase K, Ishidoya S, Arai Y, Suzuki T, Sasano H, Ishibashi T, Ito S (2007) Localization of aldosterone-producing adrenocortical adenomas: Significance of adrenal venous sampling. Hypertens Res 30: 1083-1095.
15. Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T (2002) Unique cases of unilateral hyperaldosteronism due to multiple adrenocortical micronodules, which can only be detected by selected adrenal venous sampling. Metabolism 51: 350-355.
16. Nomura K, Kusakabe K, Maki M, Ito Y, Aiba M, Demura H (1990) Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab 71: 825-830.
17. Nawata A, Takayanagi R, Miura K, Nakagawa H (1999) National Epidemiological Survey of Adrenal Hormone Production Abnormalities in the 1998 Research Reports by the Investigation and Research Group on "Adrenal Hormone Production Abnormalities" as a disease specified by the Ministry of Health, Labour and Welfare. 11-55. (In Japanese)
18. Ishidoya S, Ito A, Sakai K, Satoh M, Chiba Y, Sato F, Arai Y (2005) Laparoscopic partial versus total adrenalectomy for aldosterone-producing adenoma. J Urol 174: 40-43.
19. Tanaka M, Okegawa T, Sakai H, Tamaru S, Yoshida M, Imai T (2008) Guidelines for Laparoscopic Adrenalectomy for Adrenal Tumors. Jpn J Endourol ESWL 21: 3-14. (In Japanese)
20. Sasano H (1994) Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocr J 41: 471-482.
21. Nishikawa T, Saito J and Omura M (2007) Review Article-Prevalence of primary aldosteronism: Should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr J 54: 487-495.